SCHEMBL2490818

SCHEMBL2490818

O=C(O)CNC(=O)c1ccccc1Cl

nearest known ligand 0.63

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.63
NPC1 O15118 4/20 0.63
GPR139 Q6DWJ6 2/20 0.61
HPGD P15428 5/20 0.60
POLB P06746 2/20 0.60
CYP1A2 P05177 2/20 0.60
SMN1; SMN2 Q16637 1/20 0.58
ALDH1A1 P00352 2/20 0.54
KEAP1 Q14145 1/20 0.54
TAAR1 Q96RJ0 1/20 0.53
CYP2C19 P33261 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31448014 0.86 KEAP1 (0.62) RAB9AKEAP1TAAR1
SCHEMBL8743573 0.86 GPR139 (0.60) RAB9ANPC1GPR139HPGDPOLB
SCHEMBL11212463 0.85 HPGD (0.60) RAB9ANPC1GPR139HPGDPOLB
SCHEMBL10605231 0.85 POLB (0.64) RAB9ANPC1GPR139HPGDPOLB
SCHEMBL14597973 0.84 NPC1 (0.58) RAB9ANPC1GPR139HPGDPOLB
SCHEMBL1520287 0.82 NPC1 (0.69) RAB9ANPC1HPGDPOLBCYP1A2
SCHEMBL30289977 0.81 KMT2A (0.65) HPGDCYP1A2ALDH1A1KEAP1TAAR1
SCHEMBL27450922 0.81 KEAP1 (0.66) RAB9AALDH1A1KEAP1
SCHEMBL2491198 0.81 HPGD (0.58) RAB9ANPC1GPR139HPGDPOLB
SCHEMBL2989489 0.80 NPC1 (0.71) RAB9ANPC1GPR139HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115784914-A Preparation method of o-chlorophenylglycine 石家庄中硕科技有限公司 2023-03-14 CN claimed
CN-114685300-A Preparation method of o-chlorophenylglycine 抚顺顺能化工有限公司 2022-07-01 CN claimed
CN-116981487-A Combination of para-aminohippuric acid (PAH) and radiolabeled complexes for the treatment of cancer 同位素技术慕尼黑有限公司 2023-10-31 CN disclosed
CN-114507650-B Leucine dehydrogenase mutant and application thereof in synthesis of (S) -o-chlorophenylglycine 浙江工业大学 2023-09-05 CN disclosed
CN-217473335-U Agitated vessel is used in preparation of adjacent chlorobenzene glycine with vibration mechanism 石家庄中硕科技有限公司 2022-09-23 CN disclosed
CN-114507650-A Leucine dehydrogenase mutant and application thereof in synthesis of (S) -o-chlorophenylglycine 浙江工业大学 2022-05-17 CN disclosed
CN-214553003-U Agitated vessel is used in preparation of o chlorobenzene glycine 石家庄中硕科技有限公司 2021-11-02 CN disclosed
CN-111454933-A D-carbamoyl hydrolase mutant and application thereof in synthesis of D-aromatic amino acid 江南大学 2020-07-28 CN disclosed
EP-2061764-B1 HETEROCYCLIC DERIVATIVES BINDING TO THE PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR (PBR) TECHNION RES & DEV FOUNDATION (IL) 2014-07-02 EP disclosed
EP-2061764-B1 HETEROCYCLIC DERIVATIVES BINDING TO THE PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR (PBR) TECHNION RES & DEV FOUNDATION (IL) 2014-07-02 EP disclosed
US-8541428-B2 Heterocyclic derivatives, pharmaceutical compositions and methods of use thereof TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2013-09-24 US disclosed
WO-2002063299-A1 LOW AFFINITY SCREENING METHOD GRAFFINITY PHARMACEUTICALS AG (DE) 2002-08-15 WO disclosed
EP-1091958-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2001-04-18 EP disclosed
WO-2000001692-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2000-01-13 WO disclosed
EP-0169139-B1 HETEROCYCLIC NITROGEN COMPOUNDS, THEIR PREPARATION AND MEDICINES CONTAINING THEM SANOFI (FR) 1989-06-07 EP disclosed
EP-0315204-A2 Bleaching composition LION CORPORATION (JP) 1989-05-10 EP disclosed
EP-0169139-A1 Heterocyclic nitrogen compounds, their preparation and medicines containing them SANOFI (FR) 1986-01-22 EP disclosed
US-4359522-A Photographic element containing a UV-filter layer CIBA-GEIGY AG (CH) 1982-11-16 US disclosed
US-4350692-A CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-09-21 US disclosed
US-4148912-A ANTISECRETORY, ANTIULCER SCIENCE UNION ET CIE (FR) 1979-04-10 US disclosed